Nxera Team


Our management team, board and scientific advisory board have vast experience in the global pharma industry and provide a wealth of expertise.

A portrait of Dr. David Roblin

Dr. David Roblin

External Independent Director

David is an experienced scientist and physician, with a distinguished career in the pharmaceutical industry, most notably as Senior Vice President and Head of R&D for Pfizer in Europe along with several senior positions at Summit Therapeutics plc, the Francis Crick Institute and Bayer AG.

David is currently CEO of Relation Therapeutics Ltd and Chairman of Centauri Therapeutics Ltd, both UK-based biotechnology companies.

David has a degree in biochemistry from University of London and qualified in Medicine from St George’s Hospital, London. He is a Fellow of the Royal College of Physicians, Fellow of the Faculty of Pharmaceutical Medicine and a Fellow of the Academy of Medical Sciences. He is an honorary Professor of Medicine at Swansea University and Professor of Translational Medicine at St George’s. He also sits on a variety of committees at Wellcome, on the UK Biomedical Catalyst Fund and the LEO Foundation prize committee.

David was elected to the Nxera Pharma Board of Directors in June 2018.